Font Size Smaller Font Size
Larger Font Size
Latest Press Releases
-
August 1, 2017
FDA Grants Approval of IDHIFA®, the First Oral Targeted Therapy for Adult Patients with Relapsed/Refractory Acute Myeloid Leukemia and an IDH2 Mutation
-
July 28, 2017
Celgene Corporation to Webcast at Upcoming Investor Conference
-
July 27, 2017
Celgene Reports Second Quarter 2017 Operating and Financial Results
-
July 25, 2017
Celgene Corporation Announces Settlement of Civil Litigation
-
July 6, 2017
Celgene Corporation Enters Into Global Strategic Immuno-Oncology Collaboration with BeiGene to Advance PD-1 Inhibitor Program for Solid Tumor Cancers
No results found.